IP Verse

Bluetongue Virus Vaccine And Immunogenic Compositions, Methods Of Use And Methods Of Producing Same - EP2222335

The patent EP2222335 was granted to Pfizer Animal Health on May 10, 2017. The application was originally filed on Nov 21, 2008 under application number EP08853123A. The patent is currently recorded with a legal status of "Revoked".

EP2222335

PFIZER ANIMAL HEALTH
Application Number
EP08853123A
Filing Date
Nov 21, 2008
Status
Revoked
Jul 25, 2022
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USAFeb 8, 2018D YOUNGADMISSIBLE

Patent Citations (1) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS4545987

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- STOTT J L ET AL, "IMMUNOLOGIC RESPONSE OF SHEEP TO INACTIVATED AND VIRULENT BLUETONGUE VIRUS", AMERICAN JOURNAL OF VETERINARY RESEARCH, AMERICAN VETERINARY MEDICINE ASSOCIATION, US, (19850501), vol. 46, no. 5, ISSN 0002-9645, pages 1043 - 1049, XP009180488
INTERNATIONAL-SEARCH-REPORT- RAMAKRISHNAN M A ET AL, "Immune Responses and Protective Efficacy of Binary Ethylenimine (BEI)-Inactivated Bluetongue Virus Vaccines in Sheep", VETERINARY RESEARCH COMMUNICATIONS ; AN INTERNATIONAL JOURNAL PUBLISHING TOPICAL REVIEWS AND RESEARCH ARTICLES ON ALL ASPECTS OF THE VETERINARY SCIENCES, KLUWER ACADEMIC PUBLISHERS, DO, (20061101), vol. 30, no. 8, ISSN 1573-7446, pages 873 - 880, XP019455083 [X] 1-32 * the whole document *
INTERNATIONAL-SEARCH-REPORT- MATTION N ET AL, "Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20041022), vol. 22, no. 31-32, ISSN 0264-410X, pages 4149 - 4162, XP004594108 [A] 1-32 * page 4152, column 1, paragraph 1 *
INTERNATIONAL-SEARCH-REPORT- SAVINI ET AL, "An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy", VETERINARY MICROBIOLOGY, AMSTERDAM, NL, (20070920), vol. 124, no. 1-2, ISSN 0378-1135, pages 140 - 146, XP022190624 [X] 1-7,14-27 * the whole document *
OPPOSITION- MONDAL et al., "Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production", Biologicals, (20050000), vol. 33, pages 185 - 189, XP005013948
OPPOSITION- "Quil-A Adjuvant", InvivoGen Data Sheet, URL: http://www.invivogen.com/PDF/Quil_A_TDS.pdf, XP055463219
OPPOSITION- RAMAKRISHNAN et al., "Immune Responses and Protective Efficacy of Binary Ethylenimine (BEI)-Inactivated Bluetongue Virus Vaccines in Sheep", Veterinary Research Communications, (20060000), vol. 30, pages 873 - 880, XP019455083
OPPOSITION- BAHNEMANN, "Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine", Vaccine, (19900800), vol. 8, pages 299 - 303, XP023709570
OPPOSITION- BREARD et al., "Molecular epidemiology of bluetongue virus serotype 4 isolated in the Mediterranean Basin between 1979 and 2004", Virus Research, (20070000), vol. 125, pages 191 - 197, XP022033134

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents